5255 — Monstarlab Balance Sheet
0.000.00%
- ¥14bn
- ¥16bn
- ¥10bn
Annual balance sheet for Monstarlab, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Yuho |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4,043 | 4,242 | 2,724 | 1,783 | 1,551 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,703 | 2,546 | 3,804 | 3,522 | 885 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,916 | 7,206 | 7,818 | 5,836 | 2,723 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 657 | 333 | 654 | 615 | 227 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 9,675 | 9,909 | 12,984 | 14,461 | 7,589 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,966 | 3,727 | 5,561 | 7,932 | 5,711 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6,513 | 6,157 | 8,400 | 10,750 | 12,328 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 3,161 | 3,752 | 4,584 | 3,711 | -4,739 |
| Total Liabilities & Shareholders' Equity | 9,675 | 9,909 | 12,984 | 14,461 | 7,589 |
| Total Common Shares Outstanding |